TRUEinvivo is an in-body radiation measurement company focused on reducing patient harm in radiotherapy. They have 5 hospital partners, 6 international projects and patented CE-marked devices.

Up to 25% of the 9.5m new radiotherapy patients worldwide every year incur treatment failure, or suffer serious or long-term harm, which often require expensive further treatment. There is no accurate feedback system to show where or how much radiation is absorbed in the patient's body. Modern image-guided multi-beam radiation doses cannot be measured accurately by existing dosimeters. A 5% inaccuracy can lower treatment efficacy by 20%.

DOSEmapper1D™ is a disposable high-performance patented radiation dosimeter that measures 100+ dose points inside the patient. It is easily inserted in a catheter into the patient's natural orifice and read afterwards by DOSEmapper™ Reader (TRUEinvivo's patented automated reader) within 15 minutes.

Want to know more?

Please enter your details to download the company presentation.

    I confirm I am (choose one option)

    an Investment Professionala Certified High-Net Worth Individuala Certified Sophisticated Investora Self-certified Sophisticated Investor

    I understand this download is not investment advice or an invitation to invest

    This download is confidential. Any views or opinions in the Company Presentation are solely those of the author and might not represent those of Hyman Capital. This Company Presentation does not in any way constitute investment advice or an invitation to invest in respect of the Financial Services Acts. Any decisions or actions you make or take is completely at your own risk.